Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer
Q Pan, J Tian, H Zhu, L Hong, Z Mao… - ACS Biomaterials …, 2020 - ACS Publications
Synergetic treatments that combine chemotherapy with photothermal/photodynamic therapy
have been developed as promising new strategies for cancer therapy, especially for drug …
have been developed as promising new strategies for cancer therapy, especially for drug …
Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer
Q Pan, J Tian, H Zhu, L Hong, Z Mao… - ACS biomaterials …, 2020 - pubmed.ncbi.nlm.nih.gov
Synergetic treatments that combine chemotherapy with photothermal/photodynamic therapy
have been developed as promising new strategies for cancer therapy, especially for drug …
have been developed as promising new strategies for cancer therapy, especially for drug …
Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant Ovarian Cancer.
Q Pan, J Tian, H Zhu, L Hong, Z Mao… - ACS Biomaterials …, 2020 - europepmc.org
Synergetic treatments that combine chemotherapy with photothermal/photodynamic therapy
have been developed as promising new strategies for cancer therapy, especially for drug …
have been developed as promising new strategies for cancer therapy, especially for drug …